| # | Drug | Count |
|---|---|---|
| 0 | DROSPIRENONE AND ETHINYL ESTRADIOL | 80 |
| 1 | OMEPRAZOLE MAGNESIUM | 68 |
| 2 | OMEPRAZOLE | 54 |
| 3 | TESTOSTERONE | 45 |
| 4 | ADALIMUMAB | 44 |
| 5 | BEVACIZUMAB | 40 |
| 6 | FUROSEMIDE | 39 |
| 7 | ETONOGESTREL AND ETHINYL ESTRADIOL | 37 |
| 8 | ACETAMINOPHEN | 32 |
| 9 | METHOTREXATE SODIUM | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | 1 | 0.0769 |
| 1 | LUSUTROMBOPAG | 2 | 0.0513 |
| 2 | MENTHOL AND BENZOCAINE | 1 | 0.0185 |
| 3 | CARBON DIOXIDE | 1 | 0.0087 |
| 4 | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | 1 | 0.0081 |
| 5 | ANGIOTENSIN II | 2 | 0.0067 |
| 6 | DROSPIRENONE AND ESTETROL | 1 | 0.0034 |
| 7 | VADADUSTAT | 1 | 0.0033 |
| 8 | ETHIODIZED OIL | 4 | 0.0031 |
| 9 | NALDEMEDINE | 5 | 0.0030 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 94 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 81 |
| 2 | Proton Pump Inhibitor [EPC] | 81 |
| 3 | Estrogen [EPC] | 49 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 48 |
| 5 | Androgen [EPC] | 47 |
| 6 | Platinum-based Drug [EPC] | 45 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 42 |
| 8 | Progestin [EPC] | 41 |
| 9 | Benzodiazepine [EPC] | 40 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasoconstrictor [EPC] | 2 | 0.0067 |
| 1 | Androgen [EPC] | 47 | 0.0017 |
| 2 | Methylating Agent [EPC] | 1 | 0.0010 |
| 3 | Gonadotropin [EPC] | 2 | 0.0009 |
| 4 | Bile Acid Sequestrant [EPC] | 11 | 0.0009 |
| 5 | Plasma Kallikrein Inhibitor [EPC] | 2 | 0.0008 |
| 6 | Histone Deacetylase Inhibitor [EPC] | 3 | 0.0008 |
| 7 | Thrombopoietin Receptor Agonist [EPC] | 10 | 0.0007 |
| 8 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 3 | 0.0005 |
| 9 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |